SAP: U.S. nonprofit GENYOUth the beneficiary of the inaugural Klaus Tschira Human Resources Innovation Award $10,000 prize

WALLDORF, 13-Nov-2017 — /EuropaWire/ — SAP SE (NYSE: SAP) today announced that Shakti Jauhar, PepsiCo senior vice president of Global HR Operations and Shared Services, has selected GENYOUth, a leading U.S. nonprofit organization focused on elevating youth leadership to advance wellness in schools and communities, as the beneficiary of the inaugural Klaus Tschira Human Resources

Boehringer Ingelheim and MiNA Therapeutics partner on the development of novel compounds to treat fibrotic liver diseases

Collaboration and licensing agreement focused on investigating up to three targets and has a potential transactional value of up to EUR 307 million, excluding royalties Expands Boehringer Ingelheim’s comprehensive R&D programme in non-alcoholic steatohepatitis (NASH) and fibrotic liver disease with innovative novel treatment modalities Leverages MiNA’s leading expertise in RNA activation therapeutics, evaluating

Boehringer Ingelheim partners with the Cat Friendly Clinic programme in Europe, Asia, Africa and Australasia

The programme was set up by the International Society of Feline Medicine (ISFM), the veterinary division of the charity International Cat Care (ICC) Boehringer Ingelheim will promote the programme and develop informational tools and services to grow veterinarians’ and cat owners’ knowledge The goal is to make the clinical experience as stress-free as

Researchers developed new light-based manipulation method that could one day be used to mass produce light-based devices and electronic components

Researchers developed new light-based manipulation method that could one day be used to mass produce light-based devices and electronic components GLASGOW, 10-Nov-2017 — /EuropaWire/ — An international team of researchers has developed a new light-based manipulation method that could one day be used to mass produce light-based devices and electronic components for smartphones, computers

Novartis: positive topline results from the global MONALEESA-7 trial

MONALEESA-7 met primary endpoint of progression-free survival, demonstrating superior efficacy of Kisqali combination therapy vs. endocrine treatment alone in first-line treatment of premenopausal women with HR+/HER2- advanced breast cancer[1]  Kisqali is the first CDK4/6 inhibitor to be studied in a Phase III global trial exclusively focusing on premenopausal women with HR+/HER2- advanced breast cancer

EBRD to provide US$ 100 million loan to National Bank for Foreign Economic Activity of Uzbekistan (NBU) in support of SMEs

National Bank for Foreign Economic Activity of the Republic of Uzbekistan Financing to support small local businesses and stimulate trade LONDON, 10-Nov-2017 — /EuropaWire/ — Demonstrating the EBRD’s return to active support in Uzbekistan, the Bank is providing a major boost to local small and medium-sized businesses in the country, as well as to domestic

EBRD supported Yereymentau Wind Farm in Kazakhstan registered as domestic carbon credit project under the country’s emissions trading system (ETS)

EBRD supported Yereymentau Wind Farm in Kazakhstan registered as domestic carbon credit project under the country’s emissions trading system (ETS) Bank-supported Yereymentau project first under emissions trading system LONDON, 10-Nov-2017 — /EuropaWire/ — The Yereymentau Wind Farm in Kazakhstan, a long-standing partner of the European Bank for Reconstruction and Development, EBRD, has been registered as

EBRD President Suma Chakrabarti met with European Commission President Jean-Claude Juncker

President Suma Chakrabarti had meetings with European Commission President Jean-Claude Juncker. Focus on cooperation with EU and green finance ahead of December summit LONDON, 10-Nov-2017 — /EuropaWire/ — European Bank for Reconstruction and Development (EBRD) President Sir Suma Chakrabarti held high-level talks with officials from the European Union (EU) on 7 November. President Chakrabarti had meetings with European